Evaluation of Repeat Administration of Purified Poloxamer 188

Completed · Phase 3

Conditions studied: Sickle Cell Disease

In brief

The purpose of this study is to evaluate the safety of repeat administration of MST-188 during vaso-occlusive crisis of sickle cell disease. Additionally, this study will evaluate the development of acute chest syndrome during VOC and re-hospitalization for recurrence of VOC.

Key facts

Study ID
NCT02449616
Run by
Mast Therapeutics, Inc.
People needed
16
Starts
2015-06-01
Last updated by the study team
2016-10-28

Who can join

Age: 4 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.